Cerebral cavernous malformation (CCM) is a vascular malformation characterized by abnormally enlarged capillary cavities without any intervening neural tissue. We report 2 cases of familial CCMs diagnosed with the CCM1 mutation by using a genetic assay. A 5-year-old boy presented with headache, vomiting, and seizure-like movements. Brain magnetic resonance imaging (MRI) revealed multiple CCM lesions in the cerebral hemispheres. Subsequent mutation analysis of his father and other family members revealed c.940_943 del (p.Val314 Asn315delinsThrfsX3) mutations of the CCM1 gene. A 10-month-old boy who presented with seizure-like movements was reported to have had no perinatal event. His aunt was diagnosed with cerebral angioma. Brain and spine MRI revealed multiple angiomas in the cerebral hemisphere and thoracic spinal cord. Mutation analysis of his father was normal, although that of the patient and his mother revealed c.535C>T (p.Arg179X) mutations of the CCM1 gene. Based on these studies, we suggest that when a child with a familial history of CCMs exhibits neurological symptoms, the physician should suspect familial CCMs and consider brain imaging or a genetic assay.
Introduction
Cerebral cavernous malformation (CCM) is characterized by abnormally enlarged ca pillary cavities without intervening brain or spinal cord parenchyma. The prevalence of CCMs has been estimated to exist in 0.4% to 0.8% of the population in several reports 1) . CCMs can occur in the brain, spinal cord, retina or skin and can show numerous manife stations including headaches, focal neurologic signs, hemorrhagic stroke, seizures or sometimes even death 2) . CCMs can present sporadically or be inherited and can be autosomal dominant with incomplete penetrance. Familial CCMs are associated with the mutation of 3 genes, i.e., CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10). The CCM1 gene contains 16 cod ing exons that encode KRIT1, containing three ankyrin domains and one FERM domain. Until now, a strong founder effect has been reported in the HispanicAmerican population, and with most families linked to the CCM1 locus 3) . Our study reports the first genetically proven, Korean CCM families with CCM1 mutation.
Case reports

Case 1
A 5yearold boy presented with headache, vomiting, and seizurelike motion, although Korean J Pediatr 2016;59(6):280-284 he was without a history of trauma. On physical and neurological examination, he had no focal neurologic deficit.
The laboratory findings showed no evidence of electrolyte imbalance or other cause of his seizure. The electroencephalogram (EEG) performed one month after the seizure, revealed diffuse background slowings. Brain magnetic resonance imaging (MRI) revealed multiple CCM lesions in his cerebral hemisphere and involving the parietal and temporal lobes as well as basal ganglia (Fig. 1) .
After obtaining his family history of neurologic disease, it was revealed that his grandmother had suffered from dizziness and vomiting, and the subsequent brain MRI revealed CCM and cerebellar infarction. Familial evaluation using genetic and brain MRI screening was performed. With complete radiologic penetrance of the CCMs, his father, one uncle, and 2 aunts were all seen to have CCMs (Fig. 2 ). Mutation analysis of his family demonstrated c.940_943 del (p.Val314 Asn315delinsThrfsX3) frameshift mutation in exon 7 of the CCM1 gene of the affected family members, and which had not been previously reported (Fig.  3) . Based on the diagnosis of CCM and the associated epilepsy, oxcarbazepine was introduced and the patient had been seizure free during 3 years of medication. At this time, he has been seizurefree for 2 years after discontinuing the oxcarbazepine.
Case 2
A 10monthold boy with no perinatal events, presented with seizurelike motion. His aunt was diagnosed with cerebral angio ma (Fig. 4) . On neurologic examination, the infant had no focal neurologic deficit and no evidence of developmental delay.
EEG recording revealed 2 episodes of electrical seizures with runs of spike discharges from the left temporoparietal area. An MRI of brain and the entire spine showed multiple angioma in cerebral hemisphere and thoracic spinal cord (Fig. 5) .
Familial screening for genetic analysis of CCM1 was done and the patient and his mother demonstrated c.535C>T (p.Arg179X) heterozygous mutation in exon 5 of the CCM1 gene (Fig. 6) , and which was already known.
His seizures were wellcontrolled with the use of vigabatrin and zonisamide medications. At his 4 years of age followup, he was neurologically normal and has remained seizurefree without antiepileptic medications.
Discussion
CCMs may be both sporadic and familial. Some previous re ports have described mutation of CCM genes in worldwide famili al CCMs 46) . In this report, we describe one novel and one known mutation of the CCM1 gene occurring in two, Korean family patients with CCMs with epilepsy.
Kupfs et al. 7) first reported families affected by CCMs in 1928.
Since then there have been many studies reporting the clinical and neuroradiological features, and after which the recent development of genetic linkage analysis has allowed the full description of CCMs. In recent, large studies, CCM1 mutation showed a clinical penetrance of 62%, and several de novo muta tions have also been reported 8) . In addition, according to Gault et al. 9) , biallelic CCM1 (KRIT1) mutations, including somatic and germline truncating mutation of CCM lesions, may explain the CCM pathophysiology as that occurring in hamartomatous disease.
Recent research data allowed significant progress in deter mining the function of KRIT1 (CCM1) as a Notch activator which negatively regulates sprouting angiogenesis 10) . The loss of KRIT1 leads to an induction of angiogenesis caused by impaired DELTA NOTCH signaling, and disrupts the vascular polarity and lumen formation. Interestingly, exciting recent data suggest that the loss of KRIT1 or PDCD10 induce BMP6SMAD signaling and endo thelialmesenchymal transition contributing to the develop ment of CCM, and which leads us to search for another therapeutic option such as BMP6 or TGF β inhibitors 11) . In general, the natural course of CCMs is benign, although some patients may suffer from neurological deterioration, pri marily related to hemorrhage. According to recently published reports, infratentorial CCM lesions, especially brainstem, are more hemorrhagic events than supratentorial lesions. A larger lesion (>1 cm), early age at presentation (<35 years), and the coexistence of a developmental venous anomaly, are considered as other risk factors for hemorrhage 2) . Usually, familial CCMs are more likely to hemorrhage, grow, and present with multiple lesions than those seen in sporadic cases. In addition, a recent study regarding genotypephenotype correlations shows that CCM3 mutations are more likely to cause cerebral hemorrhage, particularly during childhood, and the increase of the number of gradientechosequence lesions with age differs according to the mutation, with a higher rate in CCM1 than in CCM2 mutations 12) . The management of CCMs includes conservative treatment, surgical resection, and stereotactic radiosurgery (SRS). In general, asymptomatic and small cavernous malformations (CMs) that are silent may be observed conservatively. Followup MRI is recommended at 1, 3, and 5 years following the diagnosis for patients younger than 45 years. In contrast, epileptogenic CMs in patients with chronic epilepsy or hemorrhagic CMs are an indi cation for surgical resection. The goal of surgery is gross total resection because incomplete resection can increase rebleeding with consequent mortality. For difficult cases, such as patients with deepseated eloquent lesions, SRS may be recommended. However, the longterm results are controversial and radiation induced morbidities are the principal drawback 13) . Several sporadic cases of cavernous malformation involving the central nervous system have been reported in the Korean population, but there are only a few studies with a genetic diag nosis and accompanying familial study. Lee et al. 14) reported the occurrence of cerebral and multiple spinal CMs with CCM3 gene mutation, and Lee, et al. 15) presented a novel mutation of the CCM1 gene related to CCM and multiple spinal CMs in Korea. In our patients, thorough historytaking and genetic screening detected familial cases of CCMs. A novel mutation of the CCM1 gene was confirmed in case 1 families over 3 generations and a detailed history provided a clue to identifying a mutation of the CCM1 gene in case 2 and his mother.
In a child with multiple CCMs, familyhistory taking, brain imaging or genetic assay should be considered in order to evaluate for familial CCMs.
